India Gets First Approved Dengue Vaccine as DCGI Clears Takeda’s QDENGA
New Delhi, July 20: In a significant milestone for India’s public health system, the Drug Controller General of India (DCGI) has granted market authorisation to Takeda Biopharmaceuticals India’s QDENGA (TAK-003), making it the country’s first approved vaccine for the prevention of dengue. Representational Image The vaccine has been approved for individuals aged 4 to 60 […]
India Gets First Approved Dengue Vaccine as DCGI Clears Takeda’s QDENGA Read More »